25522417|t|Amphetamine decreases alpha2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain.
25522417|a|BACKGROUND: The neurotransmitter norepinephrine has been implicated in psychiatric and neurodegenerative disorders. Examination of synaptic norepinephrine concentrations in the living brain may be possible with positron emission tomography (PET), but has been hampered by the lack of suitable radioligands. METHODS: We explored the use of the novel alpha2C-adrenoceptor antagonist PET tracer [(11)C]ORM-13070 for measurement of amphetamine-induced changes in synaptic norepinephrine. The effect of amphetamine on [(11)C]ORM-13070 binding was evaluated ex vivo in rat brain sections and in vivo with PET imaging in monkeys. RESULTS: Microdialysis experiments confirmed amphetamine-induced elevations in rat striatal norepinephrine and dopamine concentrations. Regional [(11)C]ORM-13070 receptor binding was high in the striatum and low in the cerebellum. After injection of [(11)C]ORM-13070 in rats, mean striatal specific binding ratios, determined using cerebellum as a reference region, were 1.4+-0.3 after vehicle pretreatment and 1.2+-0.2 after amphetamine administration (0.3mg/kg, subcutaneous). Injection of [(11)C]ORM-13070 in non-human primates resulted in mean striatal binding potential (BP ND) estimates of 0.65+-0.12 at baseline. Intravenous administration of amphetamine (0.5 and 1.0mg/kg, i.v.) reduced BP ND values by 31-50%. Amphetamine (0.3mg/kg, subcutaneous) increased extracellular norepinephrine (by 400%) and dopamine (by 270%) in rat striata. CONCLUSIONS: Together, these results indicate that [(11)C]ORM-13070 may be a useful tool for evaluation of synaptic norepinephrine concentrations in vivo. Future studies are required to further understand a potential contribution of dopamine to the amphetamine-induced effect.
25522417	0	11	Amphetamine	Chemical	MESH:D000661
25522417	22	42	alpha2C-adrenoceptor	Gene	24175
25522417	55	68	11C]ORM-13070	Chemical	MESH:C000598340
25522417	137	151	norepinephrine	Chemical	MESH:D009638
25522417	175	218	psychiatric and neurodegenerative disorders	Disease	MESH:D019636
25522417	244	258	norepinephrine	Chemical	MESH:D009638
25522417	453	473	alpha2C-adrenoceptor	Gene	24175
25522417	496	512	[(11)C]ORM-13070	Chemical	MESH:C000598340
25522417	532	543	amphetamine	Chemical	MESH:D000661
25522417	572	586	norepinephrine	Chemical	MESH:D009638
25522417	602	613	amphetamine	Chemical	MESH:D000661
25522417	617	633	[(11)C]ORM-13070	Chemical	MESH:C000598340
25522417	667	670	rat	Species	10116
25522417	772	783	amphetamine	Chemical	MESH:D000661
25522417	806	809	rat	Species	10116
25522417	819	833	norepinephrine	Chemical	MESH:D009638
25522417	838	846	dopamine	Chemical	MESH:D004298
25522417	873	897	(11)C]ORM-13070 receptor	Chemical	-
25522417	977	993	[(11)C]ORM-13070	Chemical	MESH:C000598340
25522417	997	1001	rats	Species	10116
25522417	1153	1164	amphetamine	Chemical	MESH:D000661
25522417	1219	1235	[(11)C]ORM-13070	Chemical	MESH:C000598340
25522417	1243	1248	human	Species	9606
25522417	1377	1388	amphetamine	Chemical	MESH:D000661
25522417	1446	1457	Amphetamine	Chemical	MESH:D000661
25522417	1507	1521	norepinephrine	Chemical	MESH:D009638
25522417	1536	1544	dopamine	Chemical	MESH:D004298
25522417	1558	1561	rat	Species	10116
25522417	1622	1638	[(11)C]ORM-13070	Chemical	MESH:C000598340
25522417	1687	1701	norepinephrine	Chemical	MESH:D009638
25522417	1804	1812	dopamine	Chemical	MESH:D004298
25522417	1820	1831	amphetamine	Chemical	MESH:D000661
25522417	Association	MESH:C000598340	MESH:D009638
25522417	Positive_Correlation	MESH:D000661	MESH:D009638
25522417	Association	MESH:C000598340	MESH:D000661
25522417	Negative_Correlation	MESH:C000598340	24175
25522417	Positive_Correlation	MESH:D000661	MESH:D004298
25522417	Association	MESH:D009638	MESH:D019636
25522417	Negative_Correlation	MESH:D000661	24175

